Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

Cancer is no longer a rare disease in India. Each year, more than 14 lakh people are diagnosed, and many reach hospitals only ...

A cervical cancer survivor addresses slow progress on health reforms, highlighting gaps in gynaecological cancer care in ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...

Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...

The German biotech Tubulis said it had raised a $358 million Series C round, a sizable funding that will help it push its ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral ...

Data from the Phase 1 trial of ZW191 provide readthrough to Zymeworks’ broader ADC portfolio utilizing its novel bystander active topoisomerase-1 inhibitor payload, ZD06519.

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct. 13, ...

"I began running again, and it helped me reclaim my independence and gave me back a sense of achievement that cancer temporarily took away." Ms Jordan said she would look at the race on Sunday as a ...

For the past 40 years, pink ribbons have sprouted every October as the symbol of Breast Cancer Awareness Month. To take stock of the latest in breast cancer research and the experience of patients, ...